The global surrogacy market reached a size of USD 194.0 Million in 2024 and is projected to expand to USD 321.4 Million by 2033, growing at a CAGR of 5.48% from 2025 to 2033. Market growth is fueled by rising infertility rates, increased societal acceptance of surrogacy, advancements in assisted reproductive technologies, and favorable government payment policies. The market is also impacted by fertility tourism and legal frameworks supporting surrogacy.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
Surrogacy Market Key Takeaways
- The global surrogacy market size was valued at USD 194.0 Million in 2024.
- The market is expected to exhibit a CAGR of 5.48% during 2025-2033.
- The forecast period for this report is from 2025 to 2033.
- Growth is driven by the increasing prevalence of infertility, growing awareness and acceptance of surrogacy, and legal developments creating transparent safeguards.
- Advances in IVF treatments have increased success rates, fueling the demand.
- North America dominates due to its supportive legal framework, advanced medical facilities, and high public acceptance.
- Fertility clinics are the leading service providers, offering comprehensive surrogacy services and supporting medical innovation.
Sample Request Link:
https://www.imarcgroup.com/surrogacy-market/requestsample
Market Growth Factors
The surrogacy market growth is primarily driven by the increasing incidence of infertility globally and the corresponding awareness and acceptance of surrogacy treatments. Legal improvements in various countries provide transparent regulations and safeguards, facilitating market expansion. Furthermore, technological advances in reproductive techniques, such as IVF, have boosted treatment success rates, increasing demand for surrogacy. For example, gestational surrogacy accounts for about 90% of surrogacy arrangements with a success rate around 75%, which attracts more intended parents.
Legal frameworks providing clear parental rights and protections create a safer and more trusted surrogacy process, appealing to a broader demographic including same-sex couples and individuals with infertility. Such legal support reduces legislative uncertainty and makes surrogacy services more accessible across regions.
The market also benefits from shifting societal norms and growing acceptance of nontraditional family forms, enhancing demand for surrogacy services. Studies indicating over 50% support among professionals like medical students and lawyers towards surrogacy reflect increasing knowledge and societal openness. Economic drivers include more affordable surrogacy options in certain countries, boosting fertility tourism and cross-border surrogacy arrangements due to legal and cost differences.
Market Segmentation
By Type
- Gestational Surrogacy: This segment dominates the market, involving a surrogate carrying a pregnancy genetically unrelated to her, offering benefits in reducing legal and psychological challenges. It caters to individuals and couples with reproductive issues or same-sex couples, driven by advancements in IVF accuracy increasing success rates.
- Traditional Surrogacy: Included as a segment but less dominant than gestational surrogacy.
By Technology
- IVF with ICSI: This segment holds the largest market share, employing intracytoplasmic sperm injection to overcome male infertility by injecting a single sperm directly into an egg, enhancing fertilization success and extending surrogacy applicability.
- IVF without ICSI: Present as a segment.
- Intrauterine Insemination: Included as a segment.
By Service Provider
- Fertility Clinics: The largest segment, fertility clinics provide advanced reproductive technologies, full medical assessments, and comprehensive treatment and monitoring, collaborating closely with legal and surrogacy agencies to facilitate successful pregnancies.
- Hospitals: Included as a segment.
- Others: Included as a segment.
Regional Insights
North America leads the surrogacy market, driven by a strong legal framework protecting intended parents, surrogates, and resultant children. The region's advanced fertility treatment centers, high success and safety rates, and broad public acceptance position it as the dominant market globally. The multi-ethnic population and evolving perceptions of family contribute to sustained growth and attractiveness for domestic and international intended parents.
Recent Developments & News
In June 2021, Circle Surrogacy & Egg Donation launched the "A Lifetime of Pride and Joy" campaign to promote family equality and fertility care accessibility for the LGBTQ+ community. In June 2023, Nova IVF Fertility announced a plan to expand to 100 centers across India in four years, enhancing access to fertility care. In October 2022, Ovation Fertility partnered with Genomic Prediction to advance genetic testing capabilities for fertility and family planning.
Key Players
- Bourn Hall Fertility Clinic
- Care Fertility
- Circle Surrogacy
- Extraordinary Conceptions
- Growing Generations
- Houston Fertility Center
- IVIRMA Global
- Kindbody
- Max Healthcare
- New Hope Fertility Clinic
- Nova IVF
- Ovation Fertility
Get Custom Market Research Report for Your Business:
https://www.imarcgroup.com/request?type=report&id=5298&flag=E
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
Comments (0)